Happiness Capital logo

Happiness Capital

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

Happiness Capital is a Hong Kong-based venture capital firm established in 2018, serving as the venture arm of LKK Health Products Group, a member of the venerable Lee Kum Kee Group. With a distinctive mission, the firm is dedicated to investing in startups globally that aim to enhance human happiness and well-being. Their investment philosophy centers on supporting innovative companies that contribute positively to society across various sectors, including health and wellness, sustainable living, education, and the future of work. This strategic alignment with their parent company's values provides them with a robust foundation and a long-term perspective on investment.

The firm adopts a stage-agnostic approach, deploying capital across all investment stages, from seed rounds to growth equity. This flexibility allows Happiness Capital to support promising ventures from their nascent stages through significant scaling. Their global reach is evident in a diverse portfolio that spans continents, reflecting their commitment to finding impactful innovations wherever they emerge. They seek out companies that not only demonstrate strong business fundamentals but also possess a clear vision for creating a happier and healthier future for humanity.

Happiness Capital has built an impressive portfolio of over 60 companies, including well-known names such as Calm, Impossible Foods, MasterClass, and Oatly. Their participation in significant funding rounds, such as the $175 million Series C for The Every Company or the $100 million Series C for Future Family, underscores their capacity to deploy substantial capital into high-growth ventures. While specific check sizes are not publicly disclosed, their involvement in such large rounds, coupled with their investment across all stages, indicates a readiness to write checks ranging from early-stage commitments to multi-million dollar investments in later-stage growth rounds.

Leveraging the extensive resources and global network of the Lee Kum Kee Group, Happiness Capital provides more than just capital. They offer strategic guidance, operational support, and access to a vast ecosystem, helping their portfolio companies achieve their full potential. Their unique focus on "happiness" as an investment thesis positions them as a distinctive player in the venture capital landscape, committed to fostering innovation that delivers both financial returns and positive societal impact.

Investor Profile

Happiness Capital has backed more than 29 startups, with 3 new investments in the last 12 months alone. The firm has led 10 rounds, about 34% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series B rounds (top funding stages).
  • Majority of deals are located in United States, Germany, United Kingdom.
  • Strong thematic focus on Biotechnology, Food and Beverage, Health Care.
  • Typical check size: $1M – $20M.

Stage Focus

  • Series A (34%)
  • Seed (28%)
  • Series B (17%)
  • Convertible Note (7%)
  • Series C (7%)
  • Series D (3%)
  • Series Unknown (3%)

Country Focus

  • United States (34%)
  • Germany (31%)
  • United Kingdom (17%)
  • Israel (7%)
  • France (3%)
  • Finland (3%)
  • Switzerland (3%)

Industry Focus

  • Biotechnology
  • Food And Beverage
  • Health Care
  • Health Diagnostics
  • Agtech
  • Artificial Intelligence (Ai)
  • Robotics
  • Animal Feed
  • Advanced Materials
  • Fertility
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Happiness Capital frequently co-invest with?

FoodLabs
Europe, Berlin, Germany, Berlin
Co-Investments: 5
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 5
Astanor Ventures
Europe, Luxembourg, Belgium, Luxembourg
Co-Investments: 2
GRID EXPONENTIAL
South America, Distrito Federal, Argentina, Buenos Aires
Co-Investments: 2
Rewe Group
Europe, Nordrhein-Westfalen, Germany, Cologne
Co-Investments: 3
CPT Capital
Europe, England, United Kingdom, London
Co-Investments: 4
Joyance Partners
North America, California, United States, San Francisco
Co-Investments: 2
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3
Lowercarbon Capital
North America, Wyoming, United States, Jackson
Co-Investments: 3
Clay Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2

Which angels does Happiness Capital often collaborate with?

AA
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
LL
Europe, Berlin, Germany, Berlin
Shared Deals: 1
AW
North America, New York, United States, New York
Shared Deals: 1
SB
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1

What are some of recent deals done by Happiness Capital?

Epoch Biodesign

London, England, United Kingdom

Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.

Biotechnology
Series AMar 5, 2025
Amount Raised: $18,300,000
Project Eaden

Berlin, Berlin, Germany

Project Eaden engages in the development and licensing of technologies for the production of sustainable food and meat alternatives.

Alternative ProteinInformation TechnologySustainability
Series AJan 22, 2025
Amount Raised: $15,625,016
Formo

Berlin, Berlin, Germany

Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.

BiotechnologyFood and BeverageLife Science
Series BSep 9, 2024
Amount Raised: $61,000,000
NovoNutrients

Sunnyvale, California, United States

NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and oils for aquaculture and beyond.

Animal FeedAquacultureBiotechnologyFood and Beverage
Series AJul 9, 2024
Amount Raised: $18,000,000
Infinite Roots

Hamburg, Hamburg, Germany

Infinite Roots is a biotech company that produces sustainable foods from the roots of mushrooms using fermentation.

BiotechnologyFood and BeverageHealth Care
Series BJan 25, 2024
Amount Raised: $57,481,861
CellRev

Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom

CellRev is a biotechnology company focused on process intensification within cell manufacturing applications.

Biotechnology
SeedDec 4, 2023
Amount Raised: $1,326,528
TômTex Co

New York, New York, United States

TomTex recycles agriculture waste and creates a sustainable, accessible, and practical alternatives to currently commercial materials.

Advanced MaterialsBiotechnologySustainability
SeedNov 16, 2023
Amount Raised: $2,375,000
Solar Foods

Helsinki, Southern Finland, Finland

Solar Foods is a food technology company that develops Solein, an alternative to animal-derived proteins.

BiotechnologyEnergyFood Processing
Series BNov 16, 2023
Amount Raised: $8,682,562
GOZEN

San Francisco, California, United States

GOZEN biomaterial formed by the evolutionary activity of microorganisms.

FashionTextiles
SeedOct 25, 2023
Amount Raised: $3,300,000
Vyoma GmbH

Munich, Bayern, Germany

Vyoma helps in increasing confidence in space with real-time debris observations and AI, for safe and automated satellite operations.

AerospaceArtificial Intelligence (AI)Satellite CommunicationSpace Travel
SeedJun 20, 2023
Amount Raised: $9,281,979